Ignite Creation Date:
2025-12-26 @ 10:58 AM
Ignite Modification Date:
2026-04-23 @ 6:08 AM
Study NCT ID:
NCT00858806
Status:
COMPLETED
Last Update Posted:
2014-12-03
First Post:
2009-03-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intermittent Imatinib Treatment in Chronic Myeloid Leukemia and Philadelphia Chromosome (Ph+CML) Patients Who Achieved a Complete Cytogenetic Response (CCgR) on Standard Imatinib Therapy
Sponsor:
Organization: